Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024.

Revenue
+4.29%
EPS
+2.17%
Free cash flow
+27.0%
Total debt
−18.1%

Quarter to September 2026, against a year earlier

156.13 5.30 +3.51%
Market cap
$16.8B
P/E
71.9×
Fwd P/E
66.2×
Dividend yield
0.19%
F-score
6/9
Altman Z
2.49
Beneish M
−2.45
Dividend safety
80/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
24.88 28.00 36.88 47.60 22.15 24.88 30.82 20.08 50.50 46.51
Piotroski F-Score
7 3 7 6 6 4 5 5 6 6
P/S ratio
2.74 3.60 3.13 3.73 6.01 6.10 5.38 5.01 4.97 3.95
Altman Z-Score
3.19 2.47 2.88 3.07 3.67 2.83 2.62 2.43 2.88 2.49
Altman Z″-Score (non-manufacturers)
4.04 2.60 3.09 3.18 3.58 3.01 3.45 3.70 4.33 3.86
P/FCF ratio
17.07 32.42 33.95 38.07 19.33 17.70 30.22 2,808.13 25.53 22.35
Beneish M-Score
(2.64) (2.28) (2.45) (2.45) (2.16) (2.70) (2.69) (2.32) (2.56) (2.45)
P/Operating CF
39.01 63.39 54.48 50.00 33.19 69.60 127.95 70.04 78.64 61.97
Dividend Safety Score
— — — — — — — — — 80
P/B ratio
2.69 3.24 3.36 3.82 4.28 3.27 2.41 1.75 1.79 1.56
EV/Sales
3.07 4.40 3.75 4.38 6.61 7.25 6.57 5.84 5.69 4.75
EV/EBITDA
16.34 24.24 19.76 21.02 16.38 17.23 17.79 21.72 20.10 17.71
EV/FCF
19.09 39.62 40.71 44.73 21.25 21.02 36.91 3,276.43 29.23 26.91
Current Ratio
1.97 1.26 1.60 1.80 1.36 2.01 2.13 2.07 3.60 1.68
Net Debt/EBITDA
1.73 4.41 3.28 3.13 1.48 2.72 3.22 3.10 2.55 3.00
Debt/Equity
0.49 0.80 0.73 0.74 0.53 0.70 0.60 0.50 0.41 0.44
ROE
10.99% 12.57% 9.35% 8.43% 22.23% 17.34% 7.84% 9.09% 3.48% 3.23%
ROA
5.55% 5.64% 3.94% 3.64% 10.04% 8.22% 3.91% 5.01% 2.08% 1.96%
ROIC
6.48% 4.29% 4.69% 4.82% 10.18% 6.83% 4.10% 1.85% 2.24% 2.33%
Return on Tangible Assets
32.00% 53.49% 30.44% 24.47% 76.22% 55.07% 25.56% 33.64% 12.41% 17.38%
Average Days of Receivables
73.43 89.32 83.13 91.79 158.31 67.51 67.54 83.97 83.78 95.17
Earnings Yield
4.02% 3.57% 2.71% 2.10% 4.52% 4.02% 3.25% 4.98% 1.98% 2.15%
Free Cash Flow Yield
5.86% 3.08% 2.95% 2.63% 5.17% 5.65% 3.31% 0.04% 3.92% 4.47%
Free Cash Flow per Share
3.10 2.28 2.31 2.55 7.47 11.40 4.71 0.08 4.41 4.37
Book value per Share
19.67 22.79 23.38 25.39 33.50 61.48 58.52 63.13 62.46 62.21
Free Cash Flow
339.91 250.46 255.81 282.69 832.82 1,324.73 594.18 9.90 541.65 509.41
EV/EBIT
22.03 33.57 32.15 34.93 20.28 22.04 29.28 53.46 45.24 38.07
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026